Device
Helmet CPAP
Helmet CPAP is a medical device with 5 clinical trials. Historical success rate of 40.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
40.0%
Based on 2 completed trials
Completion Rate
40%(2/5)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
3(60%)
Phase Distribution
Ph not_applicable
5
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
40.0%
2 of 5 finished
Non-Completion Rate
60.0%
3 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Terminated(3)
Detailed Status
Terminated3
Completed2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
40.0%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
terminated360%
completed240%
Recent Activity
0 active trials
Showing 5 of 5
terminatednot_applicable
CPAP Reduces Hypoxemia After Cardiac Surgery
NCT01726140
terminatednot_applicable
Pediatric Helmet CPAP Pilot Study
NCT04764929
completednot_applicable
Tidal Volume in Patients With "de Novo" Acute Hypoxemic Respiratory Failure
NCT04741659
terminatednot_applicable
Helmet CPAP Versus HFNC in COVID-19
NCT04395807
completednot_applicable
Helmet Continuous Positive Airway Pressure (CPAP) Versus Oxygen Venturi in Severe Acute Respiratory Failure in Pneumonia
NCT01383213
Clinical Trials (5)
Showing 5 of 5 trials
NCT01726140Not Applicable
CPAP Reduces Hypoxemia After Cardiac Surgery
NCT04764929Not Applicable
Pediatric Helmet CPAP Pilot Study
NCT04741659Not Applicable
Tidal Volume in Patients With "de Novo" Acute Hypoxemic Respiratory Failure
NCT04395807Not Applicable
Helmet CPAP Versus HFNC in COVID-19
NCT01383213Not Applicable
Helmet Continuous Positive Airway Pressure (CPAP) Versus Oxygen Venturi in Severe Acute Respiratory Failure in Pneumonia
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5